EUVIMEDEUVIMED entdecken
Metaanalyse

Granulocyte Colony Stimulating Factor in Improving Outcomes of Neonatal Sepsis: A Meta-Analysis

Grazielle Verzosa, Mary Mae Catherine Yu, Kathlynne Anne Abat-Senen, Maria Isabel Quilendrino

Pediatric Infectious Disease Society of the Philippines Journal · 2018

DOI: 10.56964/pidspj20181901007 ↗

Kurz gefasst

Metaanalyse in der Zeitschrift Pediatric Infectious Disease Society of the Philippines Journal, 2018. Verfasst von Grazielle Verzosa und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Neonatal sepsis complicated with neutropenia increases risk of mortality by 50%. The immature neutrophil production of neonates is often overwhelmed by severe infection. Granulocyte colony stimulating factor (G-CSF), a naturally occurring cytokine used to support neutrophil recovery during chemotherapy, is a possible treatment that can improve outcomes of neonatal sepsis.

Objectives

To determine the efficacy of G-CSF in decreasing mortality and morbidity in septic neonates. Methodology: Electronic searches were conducted on online journal databases. Unpublished or ongoing studies ere sought in training institutions accredited by the Philippine Pediatric Society. The investigators included randomized control trials using G-CSF on septic neonates.

Results

Twenty-two trials were identified and thirteen were assessed to be eligible for review. The studies had a total of 530 participants, with the largest having 78 subjects. Relative risks (RR), mean differences (MD) and standard mean differences (SMD) with 95% confidence intervals (CI) using the fixed effect model and random effects model were reported in the results. There was a significant decrease in mortality (RR 0.69, 95% CI 0.48 to 0.99) with a greater reduction for preterm neonates, low birth weight neonates and neutropenic neonates. There was no significant reduction in morbidities caused by neonatal sepsis.

Conclusions

There is moderate quality evidence that suggests that G-CSF as an adjunct treatment for neonatal sepsis significantly decreases mortality with greater benefit to preterm neonates, low birth weight neonates and those with baseline neutropenia. The studies did not show any benefit in reducing sepsis-related morbidity.

Zitieren

APA

Verzosa, G., Yu, M. M. C., Abat-Senen, K. A., & Quilendrino, M. I. (2018). Granulocyte Colony Stimulating Factor in Improving Outcomes of Neonatal Sepsis: A Meta-Analysis. Pediatric Infectious Disease Society of the Philippines Journal. https://doi.org/10.56964/pidspj20181901007

Vancouver

Verzosa G, Yu MMC, Abat-Senen KA, Quilendrino MI. Granulocyte Colony Stimulating Factor in Improving Outcomes of Neonatal Sepsis: A Meta-Analysis. Pediatric Infectious Disease Society of the Philippines Journal. 2018. doi:10.56964/pidspj20181901007

BibTeX
@article{Verzosa2018,
  author = {Verzosa, Grazielle and Yu, Mary Mae Catherine and Abat-Senen, Kathlynne Anne and Quilendrino, Maria Isabel},
  title = {Granulocyte Colony Stimulating Factor in Improving Outcomes of Neonatal Sepsis: A Meta-Analysis},
  journal = {Pediatric Infectious Disease Society of the Philippines Journal},
  year = {2018},
  doi = {10.56964/pidspj20181901007}
}
Kostenlos starten →